The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,150.00
Bid: 11,050.00
Ask: 11,250.00
Change: -50.00 (-0.45%)
Spread: 200.00 (1.81%)
Open: 11,125.00
High: 11,150.00
Low: 11,125.00
Prev. Close: 11,200.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Change

10 Sep 2020 07:00

RNS Number : 5444Y
Judges Scientific PLC
10 September 2020
 

Press Release

 

 

 

Judges Scientific plc

 

("Judges Scientific")

 

Board Change

 

Judges Scientific, the group focused on acquiring and developing companies in the scientific instrument sector, announces the appointment of Lushani Kodituwakku as an independent Non-Executive Director from 23 September 2020.

Lushani is the founder and CEO of Luminii Consulting, a consulting firm specialising in strategy, Commercial Due Diligence ("CDD") and value creation. She founded Luminii in 2017 after setting up and heading the Grant Thornton Strategy and CDD team in 2008 and holding various other senior roles with KPMG, Frost & Sullivan, PMSI and Neovian Partners.

Lushani has delivered several complex strategy & CDD projects since 1999 to large corporates, SMEs, private equity, venture capital and banks in the UK, Europe and USA looking to invest, enter new markets, diversify, redefine their business strategy and business models, making her one of the most experienced CDD and strategy advisors in the UK.

Lushani holds a Bachelor of Science (BSc) in Economics with first-class honours, and a Master of Research (MRes) in Management and Organisational Behaviour.

Lushani will also join the Remuneration committee, replacing Alex Hambro. The Board committees will comprise as follows:

Remuneration committee - Charles Holroyd (chair), Ralph Elman, Lushani Kodituwakku

Audit committee - Ralph Elman (chair), Charles Holroyd, Ralph Cohen

 

Commenting on the appointment, Alex Hambro, Chairman of Judges, said

"We are delighted to welcome Lushani to the Group. Lushani brings extensive expertise in strategy, CDD and value creation. We look forward to her guidance over the coming years as the Group continues to execute its buy and build growth strategy."

 

 

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

  Tel: +44 (0) 20 3829 6970

 

Shore Capital (Nominated Adviser & Joint Broker)

 

 

Stephane Auton

Edward Mansfield

Sarah Mather

Tel: +44 (0) 20 7408 4090

 

 

Liberum (Joint Broker)

Bidhi Bhoma

Euan Brown

 

Alma (Financial Public Relations)

Rebecca Sanders-Hewett

Sam Modlin

 

 

Tel: +44 (0) 20 3100 2222

 

 

 

 

Tel: +44 (0) 20 3405 0205

 

 

Regulatory Information

The following disclosures in relation to the appointment of Lushani Dileeka Kodituwakku, aged 46, are required pursuant to Schedule 2(g) of the AIM Rules for Companies:

 

 Current directorships and partnerships:

Past directorships and partnerships held over the last five years:

Anukampa Bhikkhuni Project

 

Ceylon Tea Centre Limited

 

Luminii Consulting

 

 

Lushani Kodituwakku has confirmed that there is no other additional information to be disclosed under Schedule 2 (g) of the AIM Rules.  

 

 

Notes to editors: 

 

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group consists of 18 businesses acquired since it was re-admitted to AIM in 2005.

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export.

 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

 

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

 

For further information, please visit www.judges.uk.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFEAAIIAIII
Date   Source Headline
25th Apr 20224:41 pmRNSHolding(s) in Company
22nd Apr 20223:37 pmRNSDirector/PDMR Shareholding
30th Mar 20223:26 pmRNSTotal Voting Rights
23rd Mar 20227:00 amRNSFinal Results
11th Mar 20227:00 amRNSDirector/PDMR Shareholding
23rd Feb 202210:44 amRNSDirector/PDMR Shareholding
14th Jan 202211:42 amRNSDirector/PDMR Shareholding
7th Jan 20227:00 amRNSFull Year Trading Statement and Notice of Results
8th Dec 20217:00 amRNSDirector/PDMR Shareholding
1st Dec 20219:57 amRNSTotal Voting Rights
30th Nov 20218:27 amRNSDirector/PDMR Shareholding
12th Nov 202111:10 amRNSDirector/PDMR Shareholding
10th Nov 20216:07 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSTotal Voting Rights
8th Oct 20219:26 amRNSDirector/PDMR Shareholding
28th Sep 20212:29 pmRNSDirector/PDMR Shareholding
24th Sep 20217:00 amRNSInterim Results
7th Sep 20212:20 pmRNSDirector/PDMR Shareholding
1st Sep 20212:34 pmRNSTotal Voting Rights
16th Aug 20217:00 amRNSDirector/PDMR Shareholding
2nd Aug 202112:19 pmRNSTotal Voting Rights
27th Jul 202111:29 amRNSDirector/PDMR Shareholding
22nd Jul 20217:00 amRNSHalf Year Trading Update and Notice of Results
9th Jul 202111:50 amRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTotal Voting Rights
10th Jun 20211:38 pmRNSBlock listing Interim Review
10th Jun 20219:49 amRNSDirector/PDMR Shareholding
28th May 20215:28 pmRNSPurchase of Ordinary Shares
28th May 20217:00 amRNSTotal Voting Rights
26th May 202112:53 pmRNSResult of AGM
26th May 20217:00 amRNSNew £60.0 million Bank Facility
20th May 202112:00 pmRNSAGM Q&A
11th May 20214:53 pmRNSDirector/PDMR Shareholding
10th May 20218:21 amRNSDirector/PDMR Shareholding
30th Apr 20217:00 amRNSTotal Voting Rights
29th Apr 202111:59 amRNSNotice of AGM
13th Apr 202111:39 amRNSDirector/PDMR Shareholding
1st Apr 202111:28 amRNSTotal Voting Rights
25th Mar 202111:58 amRNSDirector/PDMR Shareholding
23rd Mar 20217:00 amRNSFinal Results
10th Mar 20217:00 amRNSDirector/PDMR Shareholding
26th Feb 20217:00 amRNSTotal Voting Rights
16th Feb 20217:00 amRNSIncreased shareholding in Bordeaux Acquisition Ltd
9th Feb 20211:27 pmRNSDirector/PDMR Shareholding
29th Jan 20217:00 amRNSTotal Voting Rights
19th Jan 202111:57 amRNSDirector/PDMR Shareholding
8th Jan 20219:31 amRNSGrant of Options
7th Jan 20212:30 pmRNSDirector/PDMR Shareholding
7th Jan 20217:00 amRNSTrading Statement and Notice of Final Results
31st Dec 20207:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.